{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:29:22Z","timestamp":1793942962272,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.radonc.2026.111784","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:30:14Z","timestamp":1789860614000},"page":"111784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study"],"prefix":"10.1016","volume":"225","author":[{"given":"Xiaolong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-2877","authenticated-orcid":false,"given":"Kaikai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111784_b0005","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/JTO.0b013e31818020eb","article-title":"The international epidemiology of lung cancer: geographical distribution and secular trends","volume":"3","author":"Youlden","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrclinonc.2017.71","article-title":"Unravelling the biology of SCLC: implications for therapy","volume":"14","author":"Sabari","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1470-2045(21)00018-8","article-title":"The elusive pursuit of progress in limited stage small-cell lung cancer","volume":"22","author":"Senan","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. prophylactic cranial irradiation overview collaborative group","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111784_b0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/pro6.1205","article-title":"Progress in radiotherapy for small-cell lung cancer","volume":"7","author":"Yang","year":"2023","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0035","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111784_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2020.07.012","article-title":"ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer","volume":"152","author":"Le Pechoux","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1754-9485.2010.02201.x","article-title":"Involved-field radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer: disease control, patterns of failure and survival","volume":"54","author":"Watkins","year":"2010","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cncr.26119","article-title":"Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial","volume":"118","author":"Hu","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111784_b0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lungcan.2011.09.015","article-title":"Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer\u2013evidence from a phase II trial","volume":"76","author":"Colaco","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111784_b0060","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.ijrobp.2010.12.072","article-title":"Positron emission tomography\/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer","volume":"82","author":"Shirvani","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111784_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109505","article-title":"Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial","volume":"181","author":"Cui","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0070","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.21037\/tlcr-2025-409","article-title":"Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis","volume":"14","author":"Liu","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2026.111784_b0075","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.21037\/jtd.2017.10.147","article-title":"Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans","volume":"9","author":"Xia","year":"2017","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.radonc.2026.111784_b0080","first-page":"e466","article-title":"Is a clinical target volume (CTV) necessary in the treatment of lung cancer in the modern era combining 4-D imaging and image-guided radiotherapy (IGRT)?","volume":"8","author":"Kilburn","year":"2016","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.radonc.2026.111784_b0085","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1186\/s12885-024-12979-z","article-title":"Is clinical target volume necessary for locally advanced non-small cell lung cancer treated with 4D-CT intensity-modulated radiation therapy","volume":"24","author":"Ding","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2026.111784_b0090","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.21037\/tlcr-20-523","article-title":"Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique","volume":"9","author":"Zou","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.radonc.2026.111784_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.radonc.2022.07.015","article-title":"Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era","volume":"174","author":"McCall","year":"2022","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2026.111784_b0100","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111784_b0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-9-17","article-title":"Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy","volume":"9","author":"Cai","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0110","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017. Accessed February 23, 2025."},{"key":"10.1016\/j.radonc.2026.111784_b0115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111784_b0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.radonc.2026.111784_b0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11864-005-0014-1","article-title":"Combined modality therapy for limited-disease small cell lung cancer","volume":"6","author":"Raez","year":"2005","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0130","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Small Cell Lung Cancer. Version 4.2025. National Comprehensive Cancer Network. Accessed February 23, 2025, https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1462."},{"key":"10.1016\/j.radonc.2026.111784_b0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0360-3016(94)00354-N","article-title":"Dose-response relationship for radiation therapy of subclinical disease","volume":"31","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111784_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1053-4296(98)80048-9","article-title":"Radiation dose response for subclinical metastases","volume":"8","author":"Withers","year":"1998","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0145","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1259\/0007-1285-42-504-914","article-title":"The effect of oxygen on cellular survival and recovery after radiation","volume":"42","author":"Littbrand","year":"1969","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2026.111784_b0150","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2017.07.019","article-title":"Patterns of failure in limited-stage small cell lung cancer: implications of TNM stage for prophylactic cranial irradiation","volume":"125","author":"Wu","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1426635","article-title":"Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer","volume":"15","author":"Kuncman","year":"2024","journal-title":"Front Immunol"},{"issue":"suppl 1","key":"10.1016\/j.radonc.2026.111784_b0160","doi-asserted-by":"crossref","first-page":"e557s","DOI":"10.6061\/clinics\/2018\/e557s","article-title":"Radiotherapy and immune response: the systemic effects of a local treatment","volume":"73","author":"Carvalho","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.radonc.2026.111784_b0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111784_b0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00408-021-00474-2","article-title":"White blood cells in patients treated with programmed cell death-1 inhibitors for non-small cell lung cancer","volume":"199","author":"Sibille","year":"2021","journal-title":"Lung"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:14:51Z","timestamp":1793942091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026006249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S0167814026006249"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111784","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111784"}}